FdaApplication

NDA 206679

Back to search

Identifiers

Properties

PropertyValue
applicant_nameSALERNO PHARMACEUTICALS
application_typeNDA
approval_date2016-04-21

Products (2)

ProductActive ingredientStrengthDosage form
FLOLIPIDSIMVASTATIN20MG/5MLSUSPENSION;ORAL
FLOLIPIDSIMVASTATIN40MG/5MLSUSPENSION;ORAL

2 products